Kristina Marie Hernandez, NP

Kristina Hernandez practices at UC Davis Medical Center in Sacramento, California, part of University of California Health.

Kristina Hernandez's NPI, 1487252425, was assigned on October 12, 2020. Kristina Hernandez holds California license 95014658.

Kristina Hernandez's primary practice is UC Davis Medical Center, at 2315 Stockton Boulevard, Sacramento, CA 95817 in Sacramento County. The practice phone is (916) 734-2011.

Kristina Hernandez's primary practice is UC Davis Medical Center in Sacramento, California, part of University of California Health. The medical group on file is UC Davis Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Kristina Hernandez practices. Vendor and product names are available with a free account.

Nurse practitioner is Kristina Hernandez's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Kristina Hernandez is licensed in California.

CMS data shows 311 Medicare services from Kristina Hernandez across 3 procedure codes in 2024, for 113 Medicare patients. Medicare paid $18,827 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 113 Medicare patients who saw Kristina Hernandez in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have diabetes, and 75% have high blood pressure. 55% are also on Medicaid. Their average risk score is 3.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kristina Hernandez's median patient age at 59, with 55% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Kristina Hernandez for performance year 2024, reported as part of a group. Kristina Hernandez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Kristina Hernandez from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Corcept Therapeutics paid the most, $153.